Introduction 55 56
Molecular epidemiology studies in tuberculosis (TB) are generally based on 57 the universal application of a fingerprinting tool, mycobacterial interspersed repetitive 58 units-variable number of tandem repeats (MIRU-VNTR), [1] to all the 59 Mycobacterium tuberculosis (MTB) isolates in a population. MIRU-VNTR makes it 60 possible to identify clusters of epidemiologically linked isolates and thus alerts to the 61 existence of ongoing transmission chains that should be targeted by control measures. 62
Once the most relevant ongoing transmission chains have been identified in a 63 population, efforts can be prioritized to survey transmission hotspots and to track the 64 transmission of the strains involved. In some cases, specific molecular tools have been 65 developed to track selected strains [2] [3] [4] [5] [6] [7] . We proved the efficiency and flexibility of 66 a new strategy based on strain-specific PCRs targeting specific SNPs identified from 67 whole genome sequencing [8, 9] . 68
We sought a suitable scenario to further evaluate these novel surveillance 69 strategies, specifically, a context where a single high-risk multidrug-resistant (MDR) 70 strain could have a relevant role at the population level. We opted for Equatorial 71
Guinea, a small, densely populated country in central Africa, recently revealed as a 72 MDR hot-spot [10] . Indirect data point to the presence of a prevalent strain leading 73 MDR transmission in this country. We found particularly relevant data [11] showing 74 that all 10 Equatorial Guinean immigrants who arrived in Spain in different years and 75 were residing in 6 different cities shared the same MDR strain, thus suggesting 76 multiple independent importations of a highly prevalent MDR strain from the country 77 of origin. 78
In the present study, we go one step further in the application of novel 79 strategies based on WGS. Our objectives were as follows: i) to evaluate the efficiency 80 of the strategy in the most relevant challenge that TB control offers today, namely, 81 monitoring of transmission of multidrug resistance; and ii) to activate a fully 82 comprehensive design that included both the prospective surveillance of transmission 83 of MDR strains in a specific population and to perform a retrospective historical 84 analysis to locate the time-point when the culprit MDR strain emerged in that 85 population. 86 87 Methods 88 89
Clinical specimens 90
For the prospective study, we used the remnants of the mixtures of sputa with 91
GeneXpert MTB/RIF Sample Reagent (Cepheid, Sunnyvale, CA, USA) used to 92 perform GeneXpert tests in a study running between February 1 st and April 30 th 2015 93
in Equatorial Guinea [10] . The study followed the standard ethical regulations. All 94 smear-postive specimens from consecutive TB cases notified to the 2 main TB units 95 in the country during the study period were collected. Sputa were mixed 1:2 with 96 Sample Reagent and the reaction mixtures were stored at room temperature until 97 delivery to our laboratory in Madrid, Spain. Deliveries were organized to ensure a 98 maximum delay of 20 days between specimen collection in Equatorial Guinea and 99 reception in our laboratory. 100
On arrival, mixtures were used to perform the GeneXpert assay. Three 101 milliliters of the remaining mixture was used for DNA purification with a column-102 based purification method (QIAamp DNA Mini Kit; Qiagen, Courtaboeuf, France) 103 and eluted in 75 µl of buffer AE. We selected all the remnants from reaction mixtures 104 in which GeneXpert detected MTB, 105
For the retrospective analysis, we took a 100-µl microliter aliquot from the 106 isolates stored frozen at -70ºC, boiled it for 13 minutes, and centrifuged it at 13,000 107 rpm. The supernatant was taken for analysis. We designed a multiplex ASO-PCR to target 4 SNPs (Table) specific to the 128 Equatorial Guinea MDR strain (EG-MDR strain), in order to rule out false negatives, 129 as recommended elsewhere [15] . We designed 2 selective primers (SNP2 and SNP4) 130
to target the alleles found in the surveyed strain, whereas the remaining 2 primers 131 (SNP1 and SNP3) targeted the alleles from the non-surveyed strains (Table) . Our 132 design generated 2 different patterns depending on whether the strain tested was EG-133 MDR or another strain. 134
The assay conditions were 1.6 mM MgCl 2 , 1%DMSO, 0.8 µM of SNP1 City, California, USA). The PCR conditions were 95°C for 10 minutes followed by 138 30 cycles (95°C for 1 minute, 65°C for 1 minute, and 72°C for 1 minute) and 72°C for 139 SNPs, we kept 85 SNPs as potentially strain-specific for EG-MDR strain. Four of 167 these SNPs (Table) were finally selected to be targeted in a newly designed ASO-168 PCR ( Figure 1 a result that was consistent with the EG-MDR strain; only incomplete patterns (9-12 201 loci) were obtained for the remaining 7 specimens. In all cases, the allelic values 202 coincided with those of the EG-MDR strain. As for the specimen with a mixed EG-203 MDR/non-EG-MDR pattern by ASO-PCR, the mixed infection was confirmed as 204 indicated by double alleles at 5 loci, with one of the mixed MIRU-VNTR profiles 205 identical to that of the EG-MDR strain. 206
In addition to the consecutive Equatorial Guinean specimens, the ASO-PCR 207 was also applied to a selection of 6 Equatorial Guinean patients who had travelled to 208
Cameroon to receive treatment for resistant TB. In these cases, the ASO-PCR was 209 performed on the remnants received from the purified DNA used for the Genotype 210 (Hain) test performed to confirm resistance in Cameroon. The ASO-PCR revealed 211 that all 6 cases were infected by the EG-MDR strain, thus confirming its high 212 prevalence among resistant cases. 213
Second-line susceptibility patterns were obtained in a selection of 10 cases 214 infected by the EG-MDR strain. In 1 case, we detected resistance to fluoroquinolones 215 in addition to resistance to rifampicin and isoniazid. 216 217
Retrospective application of the ASO-PCR 218
Our objective was to evaluate whether the EG-MDR strain, which is highly 219 prevalent in Equatorial Guinea today, or alternatively the parental strain preceding the 220 acquisition of resistance was also present 15 years previously, when multidrug 221 resistance was not yet a major problem in the country. 222
The same ASO-PCR used to prospectively survey the EG-MDR in Equatorial 223
Guinea was now applied to a collection of MTB isolates obtained 15 years ago from a 224 population-based survey to assess resistance in Equatorial Guinea between March 225 1999 and February 2001. We selected 93 isolates, which included 1 representative 226 isolate of 18 of the 21 clusters detected in that study using IS6110-RFLP [18], and the 227 remaining orphan strains. These included the viable resistant strains from that study (9 228 isoniazid-resistant, 2 MDR, and 2 polyresistant). 229
An interpretable pattern was obtained from a crude boiled extract in all 93 230 isolates ( Figure 2) . The EG-MDR pattern was identified in 2 cases, which 231 corresponded to 2 of the 8 MDR cases in that study (1 new isoniazid+rifampicin-232 resistant case and a previously treated isoniazid+rifampicin+streptomycin-resistant 233 case). MIRU-VNTR confirmed that the pattern from the 2 cases corresponded to the 234 EG-MDR strain. The implementation of molecular epidemiology strategies in various countries 250 has demonstrated the usefulness of this approach for identifying recent transmission 251 chains and the extent to which they occur in contexts where they have been missed by 252 standard contact-tracing analysis. TB control programs could benefit from being able 253 to prioritize the often limited resources they assign to transmission control activities 254 by applying them to the transmission events responsible for the highest number of 255 secondary cases in their population. Strain-specific PCRs have been developed to 256 track the most efficiently transmitted strains in a population [2-5]. However, the 257 design of strain-specific PCRs requires in-depth knowledge of the genetic 258 composition of the strains targeted for surveillance in order to identify specific genetic 259 features or genotypic rearrangements to be targeted. Today, WGS enables us to 260 identify specific genetic features, namely, SNPs, in any strain, thus expanding our 261 capacity to design strain-specific PCRs to track the most efficiently transmitted strains 262 in a population. 263
We recently proved the effectiveness of these novel strategies for specifically 264 tracking strains transmitted efficiently in a population with a high proportion of 265 immigrants [8] and for rapid interrogation of a retrospective collection to determine 266 the presence of an outbreak strain [9]. Another example of the application of specific 267
PCRs in refining the definition of an outbreak has been published elsewhere [15] . 268
In the present study, we go one step further, by integrating these 2 challenges 269 (prospective efficient survey and fast historical analysis) into a single problem, which 270 is representative of the highest alert in TB from a clinical/epidemiological point of 271 view, namely, the transmission of multidrug resistance. The application of our strategy in this scenario enabled us to illustrate the predominance of a single MDR 273 strain in Equatorial Guinea 15 years after its emergence. 274
Our simple and fast test was able to identify cases infected by the prevalent 275 EG-MDR strain, even in a challenging analytical situation, because cultured isolates 276
were not available. Our test performed well with the remnants of GeneXpert reaction 277 mixtures, and we observed a high percentage of interpretable results (93%), 278
considering that remnants were stored at room temperature for several weeks before 279 being sent to our laboratory for analysis. 280
The potential of GeneXpert remnants as templates for molecular epidemiology 281
analysis had not been previously tested. Our results highlight the value of the 282 combination of cheap and easy-to-implement surveillance tests with the stabilized 283 extracted material offered by GeneXpert, which is used worldwide, even in most low-284 resource countries. Replicating our strategy could improve our limited knowledge of 285 the molecular epidemiology of TB in many low-resource settings, even in those where 286 culture facilities are not available. 287
One interesting additional finding was the identification of a mixed infection 288 involving an EG-MDR strain and another strain. Although data available were not 289 sufficient to rule out the involvement of cross-transmission it illustrates the ability of 290 the technique to identify simultaneous infections by more than one strain. 291
One added value of our strategy was that it enabled us to integrate the 292 prospective survey of the prevalent EG-MDR strain with parallel historical tracking of 293 its emergence in the country. The simplicity of our design facilitated transfer of the 294 reagents to the laboratory in Barcelona, where the isolates obtained in the first 295 molecular epidemiology study run in Equatorial Guinea 15 years ago were stored 296
[18]. The sensitivity of the test made it possible to analyze the stored isolates directly 297 from a crude boiled extract, without the need to subculture or purify DNA, thus 298 making the test fast and inexpensive. 299
Two cases were infected by the EG-MDR strain in the retrospective collection. 300
During those years most cases were monoresistant to isoniazid, and only 8 cases 301
(3.4%) were MDR [19]. One of the 2 cases was newly diagnosed and the other 302 previously treated. 303
Our findings provide a snapshot of 2 relevant moments in the history of 304 multidrug resistance in Equatorial Guinea. The first was the emergence of an MDR 305 strain, most likely in a treated case 15 years ago. In the second, we see the dramatic 306 consequences of this emergence because today, the same strain is responsible for half 307 of all resistant cases in the country, most likely because of transmission, as indicated 308 by the fact that the EG-MDR strain is mainly isolated from new cases (data not 309 shown). 310
The identification of representatives of the EG-MDR strain 15 years apart 311
offers an extraordinary opportunity to analyze the variability acquired by an MDR 312 strain over a long period. Surprisingly, for an MDR strain that was actively 313 transmitted over such a long period (when compensatory mutations and additional 314 variability are likely to be expected) [20, 21], we observed low variability based on 315
SNPs within the same range as that expected in a standard recent transmission chain 316 occurring over a limited period [22] . This finding is consistent with one of the 317 peculiarities of Equatorial Guinea: the lack of a national program to treat MDR-TB 318 means that the EG-MDR strain has not been exposed to efficient therapeutic 319 regimens, thus obviating the selection of variability that had likely occurred under 320 standard anti-TB selective pressure. 321
It is particularly worrying that, compared with its historical ancestor, the EG-322 MDR strain developed additional resistance within this prolonged transmission 323 dynamic (ethambutol and pyrazinamide, 1 isolate; fluoroquinolones, 1 isolate). The 324 acquisition of resistance to fluoroquinolones is probably due to the frequent use of 325 ciprofloxacin in many African countries, as recently stated in a report alerting to the 326 cross-border migration of MDR cases from Equatorial Guinea to Cameroon to receive 327 treatment [23]. In a sample of patients who migrated to Cameroon, all members were 328 infected by the EG-MDR strain, thus highlighting the importance of tracking the 329 potential transmission of the EG-MDR strain in the neighboring country. The final 330 objective of our strategy, which was based on tailoring a strain-specific PCR to 331 address local transmission challenges, is to transfer the tests to be implemented 332 locally. We are collaborating with Bamenda hospital in Cameroon to implement the 333 EG-MDR-specific PCR locally and optimize rapid analysis in situ. 334
Our study enabled us to analyze the dramatic consequences of the emergence 335 of a MDR strain 15 years ago that is responsible for half of the MDR cases in 336 Equatorial Guinea today. Transmission was likely enhanced by the dramatic 337 socioeconomic transformation of the country and the lack of a national program to 338 treat MDR-TB. This worrying situation must be appropriately managed to minimize 339 the impact on both neighboring countries and on host countries receiving immigrants 340 from this area. Our novel strategy, which integrated WGS analysis and strain-specific 
